$NERV

Wall Street Zen upgraded Minerva Neurosciences (NASDAQ:NERV) from "sell" to "hold," although the consensus rating on MarketBeat remains "Reduce." The company reported a quarterly EPS of -$0.36, missing estimates, and institutional ownership stands at approximately 34.56%. The stock's current market cap is $169.62 million with a P/E ratio of -2.12.